Company to pay 35 million dollar for falsely marketing cholesterol drug Ruby Khatun Khatun25 Sep 2017 5:12 AM GMTBOSTON: A Massachusetts drug company has agreed to pay more than $35 million to resolve criminal and civil charges that it falsely marketed a...